Teva Pharmaceutical Industries Limited (TEVJF) Financials

TEVJF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 39.9 billion 32.1 billion
March 31, 2026 40.0 billion 31.9 billion
Dec. 31, 2025 40.7 billion 32.8 billion
Sept. 30, 2025 39.9 billion 32.6 billion

TEVJF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 307.0 million 40.0 million
March 31, 2026 -208.0 million 43.0 million
Dec. 31, 2025 721.6 million 51.0 million
Sept. 30, 2025 233.0 million 34.0 million

TEVJF Net Income

No data available :(

TEVJF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.7 billion 12.1 billion 282.0 million
March 31, 2026 3.7 billion 14.1 billion 280.9 million
Dec. 31, 2025 3.6 billion 15.0 billion 382.1 million
Sept. 30, 2025 2.2 billion 16.8 billion 283.0 million

TEVJF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.2 billion
March 31, 2026 1.2 billion
Dec. 31, 2025 1.2 billion
Sept. 30, 2025 1.2 billion

TEVJF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 104.0 million 970.0 million 1.0 billion 717.0 million
March 31, 2026 168.0 million 222.0 million 1.0 billion 696.0 million
Dec. 31, 2025 142.0 million 267.0 million 1.1 billion 753.0 million
Sept. 30, 2025 136.0 million 255.0 million 975.0 million 657.0 million

TEVJF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 4.1 billion 2.0 billion
March 31, 2026 4.0 billion 2.0 billion
Dec. 31, 2025 4.7 billion 2.1 billion
Sept. 30, 2025 4.5 billion 2.2 billion

TEVJF Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TEVJF

Price: $38.98

52 week price:
14.32
39.70

Dividend Yield: 3.01%

Payout Ratio Range:
-300.00%
278.64%

Earnings Per Share: 0.60 USD

P/E Ratio: 47.33

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 45.4 billion

Links: